Painchek Share Price and Company Fundamentals



Price
$0.097
Change
0.000 (0.000%)
52 week range
0.092 - 1.05

Last traded: Yesterday at 11:59 PM

PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

-

Beta

0.47

Market cap

$20.27M

Enterprise value

$18.53M

Company profile

Industry / Sector Health Information Services / Healthcare
Website https://www.painchek.com
Mailing address 35 Lime Street Suite 401 Sydney NSW 2000 Australia
Phone / Fax 61 4 2125 2123 / 61 8 9388 8256

Dividends

More: Painchek Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Painchek paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PCK dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Sep 2026, following are the company executives and directors listed on Painchek.

Name Title Age Total Pay
Mr. Iain McAdam Chief Financial Officer
Mr. Andrew Hoggan Chief Operating Officer
Prof. Jeff Hughes Ph.D. Chief Scientific Officer
Mr. David Allsopp GM & Head of Business Development of North America
Ms. Sasha Grant Head of Growth for PainChek Infant App
Tandeep Gill GM and Head of Business Development of UK&I
Ms. Natalie Sylvia Climo L.L.B. Company Secretary

Profitability and management effectiveness

Profit margin

-238.78%

Operating margin

-202.21%

Return on assets

-112.03%

Return on equity

-

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Painchek is 20.27M and its enterprise value is 18.53M. The enterprise value to revenue ratio of PCK is 4.95. The enterprise value to EBITDA ratio of PCK is -2.12.

The PCK's stocks Beta value is 0.47 making it 53% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Painchek (PCK)

Painchek (ASX:PCK) Frequently Asked Questions

1. What is Painchek's Stock Symbol?

Painchek trades on ASX under the ticker symbol "PCK".

2. What is Painchek's stock price today?

One share of PCK stock can currently be purchased for approximately $0.097.

3. How can I contact Painchek?

Painchek's mailing address is 35 Lime Street Suite 401 Sydney NSW 2000 Australia. The company can be reached via phone at 61 4 2125 2123.

4. What is Painchek's official website?

The official website of Painchek is https://www.painchek.com.